SCHEMBL1699442

SCHEMBL1699442

CCc1c(OS(=O)(=O)C(F)(F)F)ccc2c(-c3ccc(Cl)cc3)c(C(O)C(=O)O)c(C)cc12

nearest known ligand 0.34

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
PPARG P37231 7/20 0.34
PPARD Q03181 7/20 0.34
PPARA Q07869 7/20 0.34
PTGDR2 Q9Y5Y4 6/20 0.33
FFAR4 Q5NUL3 1/20 0.32
DRD2 P14416 1/20 0.31
DRD1 P21728 1/20 0.31
DRD4 P21917 1/20 0.31
DRD5 P21918 1/20 0.31
DRD3 P35462 1/20 0.31
MMP2 P08253 1/20 0.31
MMP9 P14780 1/20 0.31
SMN1; SMN2 Q16637 1/20 0.31
TSHR P16473 1/20 0.31
HTR2A P28223 1/20 0.31
HTR2C P28335 1/20 0.31
HTR2B P41595 1/20 0.31
EPAS1 Q99814 2/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1699571 0.80 PTGDR2 (0.37) PTGDR2HTR2C
SCHEMBL10272102 0.75 PTGDR2 (0.37) PPARAPTGDR2SMN1; SMN2TSHRHTR2A
SCHEMBL1699760 0.69 PTGDR2 (0.35) PPARGPPARDPPARAPTGDR2MMP2
SCHEMBL1699307 0.68 CYP3A4 (0.45) PPARGPTGDR2
SCHEMBL10271593 0.67 CYP3A4 (0.38) PPARAPTGDR2SMN1; SMN2TSHRHTR2A
SCHEMBL1699408 0.67 CYP19A1 (0.42) PPARGTSHR
SCHEMBL1699420 0.65 MTNR1B (0.38)
SCHEMBL28334586 0.64 SLC6A2 (0.40) PTGDR2DRD2DRD1DRD4DRD5
SCHEMBL31204476 0.64 TSHR (0.46) TSHRHTR2AHTR2CHTR2BEPAS1
SCHEMBL1701440 0.64 ALDH1A1 (0.42) SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2588450-A1 NAPHT- 2 -YLACETIC ACID DERIVATIVES TO TREAT AIDS Gilead Sciences, Inc. (US) 2013-05-08 EP disclosed
WO-2012003497-A1 NAPHT- 2 -YLACETIC ACID DERIVATIVES TO TREAT AIDS GILEAD SCIENCES, INC. (US) 2012-01-05 WO disclosed